Pharmasset to Present at Goldman Sachs and Needham Healthcare C... ( PRINCETON N.J. June 2 /- Pharmasset I...)

Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences

Date:6/2/2009

PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces management will present at the Goldman Sachs Global Healthcare Conference and the Needham Healthcare Conference. Both conferences will be held in New York, NY.

Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the Goldman Sachs Global Healthcare Conference on Tuesday, June 9, 2009 at 3:10 PM (ET) and at the Needham Conference on Thursday June 11, 2009 at 1:00 PM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the developme
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. Pharmasset Reports Fiscal Year End 2008 Financial Results
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
8. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
9. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
11. Pharmasset Receives Notice of Allowance

Post Your Comments:

(Date:7/31/2014)... ResMed Inc. (NYSE: RMD ) today announced ... ended June 30, 2014. Revenue for the quarter was $415.2 ... (a 1 percent decrease on a constant currency basis). Net ... to the quarter ended June 30, 2013. Diluted earnings per ... percent compared to the quarter ended June 30, 2013. ...

(Date:7/31/2014)... Calif., July 31, 2014 Pharmacyclics, Inc. (the "Company") ... recent developments for the quarter ended June 30, 2014. ... June 30, 2014 Revenue Total revenue for the quarter ... million for the quarter ended June 30, 2013 primarily due ... million. Total revenue for the six months ...

(Date:7/31/2014)... MOUNTAIN VIEW, Calif. , July 31, 2014 ... ) today provided an update on its pipeline ... of 2014, Alexza expects to initiate a Phase ... which is being developed for the management of ... identified two new Staccato -based product candidates ...

[0] RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 [0] Pharmacyclics Reports Second Quarter 2014 Results [0] Alexza Provides Pipeline Update

... Contaminated with Diethylene Glycol,(DEG) Remains a Potential ... Md., May 4, 2007-The U.S. Food and ... repackers, and health professionals who compound,medications to ... a,sweetener commonly used worldwide in liquid over-the-counter ...

... ROCKVILLE, Md., April 25, 2007-The U.S. Food ... a Consent Decree of,Permanent Injunction against PharmaFab ... officials, Mark Tengler, PharmaFab's president,and Russ McMahen, ... the illegal manufacture and distribution of prescription ...

Cached Medicine Technology:FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2 Major Manufacturer of Unapproved and Adulterated Drugs 2 Major Manufacturer of Unapproved and Adulterated Drugs 3

FDA Advises Manufacturers to Test Glycerin for Possible,Contamination Major Manufacturer of Unapproved and Adulterated Drugs

(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation ... therapy caused strokes, heart attacks, and other injuries in ... F. Kennelly as the transferee judge and ordered what ... federal court. , As one of his first organizing ... of attorneys who will move the litigation forward on ...

(Date:8/1/2014)... central role in regulating appetite and whole-body metabolism. A ... control of food intake and body weight, but the ... unclear. A new study in the ... in a type of neuron known as pro-opiomelanocortin (POMC) ... diet. Sabrina Diano and colleagues at Yale University ...

(Date:8/1/2014)... 2014 Stryker hip lawsuits ( ... 2012 Rejuvenate and ABG II Modular-Neck Hip Stem ... Bergen County Superior Court, Bernstein Liebhard LLP reports. ... Court has issued a Final Amended Stipulated ... hard copy and electronic materials produced by any ...

(Date:8/1/2014)... CLEVELAND, Ohio In a first-of-its-kind study, researchers at ... found that lap infants may be at greater risk ... analyzed pediatric medical emergencies on flights worldwide between January ... deaths occurred in children under the age of 2. ... MedAire to characterize the rare event of an in-flight ...

(Date:8/1/2014)... Vegas, NV (PRWEB) August 01, 2014 ... and opportunities for independent community pharmacies. At ThoughtSpot ... pharmacists are equipped with practices and resources to ... Session, AmerisourceBergen leaders focused on critical issues to ... learn, optimize and grow. , ThoughtSpot show ...

Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2 Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2 Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3 Health News:New research characterizes in-flight pediatric deaths 2 Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2 Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3 Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4 Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5

[0] Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL [0] Understanding how neurons regulate metabolism in response to a high-fat diet [0] Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports [0] New research characterizes in-flight pediatric deaths [0] ThoughtSpot 2014 Inspires as General Session Concludes

... "Thomson Reuters Citation Laureates" Recognized for Their,Contributions to ... Oct. 1 The Scientific business,of Thomson Reuters ... researchers likely to be in contention for Nobel ... winners to be announced in October., Each ...

... of serious public health issue through first ... Sudden cardiac arrest (SCA) claims,more lives each year ... a new Heart Rhythm Society survey, four out of ... health issue that causes,more than 250,000 deaths each year. ...

... developed a method of using nanoparticles to deliver treatments ... team led by Richard Borgens of the School of ... of Biomedical Engineering coated silica nanoparticles with a polymer ... That research is being published in the October edition ...

... Recession Fears - List Reports Aggregate Revenue of $185 Billion; Nuclear ... 100 Health Companies and No. 1161 on the Inc. 5000 With ... ... (PRWEB) October 1, 2008 -- Inc. today ranked www.mobilenuclear.com [Nuclear Medicine ...

... Ticker Symbol: CUR, QUEBEC CITY, Oct. 1 ... company commercializing high-value cancer diagnostic,tests and delivering laboratory ... CEO of the Company, will be presenting a ... Focus Conference on,Monday, October 6, 2008, at 1:30 ...

... with No Monthly ... Premium, ... serving seniors and others with Medicare,announced today that its new Medicare Advantage ... with no monthly plan premiums and no deductibles., "Access to affordable, ...

Cached Medicine News:Health News:The Scientific Business of Thomson Reuters Predicts Nobel Laureates 2 Health News:The Scientific Business of Thomson Reuters Predicts Nobel Laureates 3 Health News:The Scientific Business of Thomson Reuters Predicts Nobel Laureates 4 Health News:The Scientific Business of Thomson Reuters Predicts Nobel Laureates 5 Health News:New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest 2 Health News:New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest 3 Health News:New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest 4 Health News:Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries 2 Health News:America's 5000 Fastest-Growing Private Companies Revealed 2 Health News:DiagnoCure to present at the JMP Securities Healthcare Focus Conference on October 6, 2008 2 Health News:SCAN Health Plan Arizona Announces Its 2009 MAPD Benefits for Maricopa County 2

The Scientific Business of Thomson Reuters Predicts Nobel Laureates New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries America's 5000 Fastest-Growing Private Companies Revealed DiagnoCure to present at the JMP Securities Healthcare Focus Conference on October 6, 2008 SCAN Health Plan Arizona Announces Its 2009 MAPD Benefits for Maricopa County

... Slimline single-use pH catheters are ... cross-contamination and allow greater patient comfort ... ,Medtronic pH measurement systems have been ... that allow an accurate room-temperature calibration. ...

FLEXILOG spare part....

Complete calibration kits are available for both pH and manometry systems....

Medicine Products:

Slimline Single-use (SU) pH Catheter FLEXILOG 3000 Data Download Cable FLEXILOG 2000 Data Download Cable pH Calibration Kit (pH1.07 and pH7.01)